Aclaris Therapeutics stock price
애클래리스 테라퓨틱스NASDAQ:ACRS · Nasdaq · Healthcare$4.27-2.73%
2026-10-05 close · prelimLoading chart…
Today's signals · No active technical signal.
Signal details →Aclaris Therapeutics last closed at $4.27 (-2.73%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -8.3×. Its overall grade ranks 549 of 739 stocks in Healthcare.
About this company
Aclaris Therapeutics last closed at $4.27 (-2.73%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C · 549/739
Valuation grade B
Related stocks
- AmgenCompetitor
Aclaris와 같은 자가면역·염증성 질환 치료제 개발 영역에서 경쟁하는 대형 바이오 기업
- AbbVieCompetitor
면역·염증성 질환 치료제 포트폴리오를 보유한 주요 경쟁사
- PfizerCompetitor
면역·염증성 질환 및 면역조절 치료제 분야에서 경쟁하는 대형 제약사
About Aclaris Therapeutics
- What technical signals does Aclaris Therapeutics (ACRS) have?
- Aclaris Therapeutics current technical signals: no active technical signal.
- Is Aclaris Therapeutics a cup-and-handle pattern?
- No. Aclaris Therapeutics has no valid Cup signal right now.
- What published figures are available for Aclaris Therapeutics?
- Market cap: $462.63M. Trailing 12 months PER: -8.3×. Latest quarter PBR: 5.03×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-05 dataset
Turn what you saw on this name into a strategy
Ask Q about Aclaris Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy